Best Grants for Digestive System Health and Diseases in Missouri

Nonprofit 501(c)(3) organizations in Missouri working on economic and workforce advancement, safe and affordable housing, or community arts and culture may be eligible for grants that support programs and services. Grants from US Bancorp Foundation help community-focused nonprofits, including those addressing health-related inequities, advance equitable, high-impact initiatives in designated U.S. Bank communities.

American Gastroenterological Association

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA represents members from around the globe who are involved in all aspects of the science, practice, and advancement of gastroenterology. The AGA Institute administers the practice, research, and educational programs of the organization.

AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease

This award provides funding for three years to early-career faculty (i.e., investigator, instructor, research associate or equivalent) working toward an independent career in inflammatory bowel disease (IBD) research.

Objective

The objective of the AGA Research Foundation Research Scholar Award (RSA) is to support early-career investigators working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for mentored research (i.e., a minimum of 50 percent effort dedicated to the proposed project). This award will support junior faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research pertaining to inflammatory bowel disease.

Review all of the benefits AGA Research Scholar Award recipients are entitled to on the award policies page.

Application Requirements

• Maintain AGA membership throughout the three-year duration of the award.

• Applicants must self-assign their proposal to one of the following categories:
  • Clinical: Research involving direct contact with human subjects or using clinical data to address problems related to the prevention, diagnosis, treatment or outcome of human diseases (e.g., clinical epidemiology). This category also includes research related to health care delivery (e.g., health services, health IT).
  • Basic/Translational: Research with a primary goal of understanding basic biology or disease mechanisms. This category can involve animal subjects, cell culture, human biospecimens or human data as resources for laboratory- or informatics-based investigation.

• Resources allocated through this award are intended to support the career development of the applicant. The applicant must allocate a minimum of 50 percent effort to the proposed project.

• Applicants are required to have a sponsor and mentor for the award; one individual may serve in the capacity of both positions. A sponsor (typically a division chief or department chair) is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A mentor will supervise the principal investigator’s research activities ensuring timelines and deliverables and will work with the applicant to create a research career development plan.

• The intent of this award is to foster the scientific independence of junior investigators. Applicants whose research activities become incorporated into a grant application from a senior mentor will need to delineate clearly the scientific and experimental distinctions between their respective programs. This requirement applies both to pending applications submitted prior to review of this award and to applications submitted during the term of the RSA. It must also be clearly stated how the work submitted by the applicant is that of the applicant and not that of the senior mentor(s).

• A complete research facilities and resources form must be submitted.

• Biographical sketches for the applicant, mentor and other key personnel must be submitted.

• Applicants resubmitting a revised application from a prior cycle must include a resubmission report describing responses to reviewer feedback and other major changes since the most recent past submission.

• Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee(s) for use of human subjects or animals. If approval is not necessary, then the recipient must provide documentation from the appropriate regulatory committee.

• Recipients must submit scientific and financial progress reports to AGA annually and final reports 60 days after the end date of the award period. Report templates and instructions are provided to awardees at the time of acceptance. Second and third year funding are contingent upon the submission and accuracy of this documentation.

• All publications, presentations, abstracts, and patent applications arising from work funded by this program must acknowledge support of the AGA–Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease.

• Additional pre-award policies are available on the Research Award Policies page.

Award Overlap

• At the time of application submission, applicants may not hold, or have held, an NIH K01, K08, K23, K99, R00, R01, R21, R29, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (e.g., the American Liver Foundation, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation).

• Applicants who have held a K12 or KL2 in the past are eligible to apply. Applicants with an active K12 or KL2 may apply in the final year of their active K12 or KL2 so long as the award will end before the Research Scholar Award term begins.

• If a applicant is granted the award and notified of a comparable award from another agency prior to the first payment of this award, then the recipient must select one of the two awards (i.e., the recipient may not retain both awards).

• If the recipient is notified that a comparable award has been granted after the first payment of this award, then the recipient may retain up to 50 percent of the remainder of his or her AGA award. AGA must be notified by the recipient via email within two weeks of receiving notification of additional funding.

Missouri digestive health researchers and clinicians can access funding for epidemiologic studies using GIQuIC data to evaluate GI endoscopy use, quality, and outcomes. The American College of Gastroenterology and ASGE co-sponsor this award, offering up to US $50,000 to ACG or ASGE member physicians, clinical researchers, and eligible fellows in the U.S. or Canada.

American College of Gastroenterology provides Missouri digestive health researchers with up to US $75,000 for patient-oriented gastrointestinal and liver disease health equity studies. U.S. or Canadian ACG-member physicians in gastroenterology or hepatology with faculty or community practice appointments can investigate disparities affecting racial/ethnic minorities, women, LGBTQ+ people, and people with disabilities, advancing clinical care and outcomes.

Established ACG-member clinical investigators in gastroenterology or hepatology in Missouri and across the U.S. and Canada can apply for the Established Investigator Bridge Funding Award, offering up to US $300,000 over two years to sustain patient-oriented digestive or liver disease research programs during gaps in federal funding. Eligible physicians must hold full-time faculty appointments and show recent and ongoing federal grant activity.

Junior gastroenterology and hepatology faculty in Missouri and across the U.S. or Canada can seek up to US $450,000 for three years of clinical research career development. Focused on digestive and liver diseases, the American College of Gastroenterology award supports 50% protected research time for ACG member physicians less than seven years post-fellowship.

With a mission to advance nonmalignant hematology research, the National Institutes of Health provides Missouri medical and research institutions with R01 funding for basic and early translational studies. Projects may explore links between blood disorders and digestive system, kidney, metabolic, aging, cardiovascular, respiratory, or sleep-related conditions across the U.S., including Missouri.

Registered nurses conducting pediatric gastrointestinal, hepatobiliary, pancreatic, or nutrition research and quality improvement projects can receive US $500 - US $10,000, including those based in Missouri. Grants from the North American Society for Pediatric Gastroenterology, Hepatology & Nutrition support APGNN members in the U.S. and Mexico advancing nursing care for affected children and families.

Early-career MD or PhD investigators at U.S. nonprofit or government institutions conducting pediatric inflammatory bowel disease research can seek three-year career development support, including salary and research expenses, from this program. Focused on digestive system health, the Crohns and Colitis Foundation invites Missouri-based researchers to pursue mentored projects using resources such as IBD Plexus, with awards ranging from US $102,500 - US $307,500.

Missouri digestive health researchers can access funding through the North American Society for Pediatric Gastroenterology, Hepatology & Nutrition’s George Ferry Young Investigator Development Award, which offers US $150,000 for pediatric GI, liver, pancreas, or nutrition research. Early-career NASPGHAN-member faculty in the U.S., Canada, or Mexico within five years of fellowship completion may be eligible.

Grants from the North American Society for Pediatric Gastroenterology, Hepatology & Nutrition help Missouri digestive health programs by funding mentored summer research experiences for medical students. Students in good standing at accredited U.S. or Canadian medical schools can receive up to US $4,000 for a 10-week, pediatric-focused gastroenterology, hepatology, or nutrition research project under faculty mentorship.

Health and research organizations addressing liver disease and liver cancer disparities can access funding in Missouri and nationwide through the National Institutes of Health. NIH provides Missouri digestive health programs with support for multi-level or multi-domain interventions to reduce liver disease and liver cancer disparities among populations experiencing health inequities in the U.S., including territories.

General surgery residents and recent graduates conducting clinical or lab research on diseases of the colon, rectum, or anus may be eligible for funding that supports digestive system health in Missouri and beyond. Focused on colorectal disease research, the American Society of Colon & Rectal Surgeons offers US $20,000 for direct research costs, salary, or living expenses.

Focused on clinical colorectal surgery research, the Research Foundation of the American Society of Colon & Rectal Surgeons invites investigators in Missouri and across the U.S. and Canada to apply for the Eugene Salvati, MD, Limited Project Grant. Eligible colorectal surgery residents or trained surgeons can receive up to US $25,000 for investigator-initiated, hypothesis-driven clinical projects on colorectal disease.

Digestive health researchers in Missouri studying colon and rectal diseases can seek up to US $25,000 for one-year, investigator-initiated, hypothesis-driven projects conducted in the U.S. or Canada. The American Society of Colon & Rectal Surgeons’ Research Foundation supports ASCRS-member-led projects that can advance colorectal surgery and help secure future national funding.

Nonprofit research institutions and clinical teams in Missouri working on digestive system health and diseases can seek up to US $20,000 for investigator-initiated colorectal surgery and health equity projects. With a mission to improve colorectal care, American Society of Colon and Rectal Surgeons provides support for pilot interventions, community outreach, workforce diversity, and access-focused initiatives in the U.S. and Canada.

The Robotic Research Grant, offered by the American Society of Colon and Rectal Surgeons, provides up to $150,000 over two years for innovative research in colorectal surgery and robotics. Emphasizing education, health equity, and novel techniques, the grant supports projects conducted in the U.S. or Canada, with a focus on scientific rigor. Applications must be submitted by ASCRS members who are principal investigators, ensuring alignment with ethical research standards.

Graduate students, medical students, and early medical residents in Missouri working on digestive system research can receive US $500 - US $1,000 to support abstract-based presentations at Digestive Disease Week. American Gastroenterological Association funding recognizes exceptional gastroenterology and hepatology abstracts from trainees at North American institutions and encourages applicants from underrepresented groups.

The NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional) program invites applications to support innovative biomedical research focused on cystic fibrosis, diabetes, and other chronic diseases. These centers foster collaboration, provide essential resources, and mentor early-stage investigators, enhancing the research landscape. Funding will support pilot programs and access to shared services, ensuring efficient use of resources while promoting a robust scientific community dedicated to advancing health outcomes.

The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC) aims to enhance understanding of gastrointestinal disorders by expanding the previous Gastroparesis Consortium's research scope. This initiative will include adult and pediatric conditions linked to impaired interoceptive processing, utilizing multidisciplinary approaches to uncover mechanisms connecting GI function to symptoms, identify biomarkers for treatment efficacy, and explore new therapeutic targets for future clinical trials.

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center aims to enhance understanding of inflammatory bowel disease (IBD) by coordinating extensive genetic research. By leveraging diverse patient cohorts and advanced data science techniques, the center seeks to identify genetic risk factors, develop predictive biomarkers, and improve IBD patient management. This initiative will facilitate collaboration among various research centers and ensure efficient data collection and sharing to foster advancements in precision medicine for IBD.

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) aims to enhance understanding of inflammatory bowel diseases (IBD) through genomic research. By leveraging patient cohorts and advanced data science, the IBDGC seeks to identify genetic risk factors and develop predictive biomarkers for disease outcomes. This initiative will improve medical management and advance precision medicine for IBD patients, addressing the need for effective diagnostics and treatment strategies in this chronic condition.

The NIDDK is expanding its Gastroparesis Consortium into the Disorders of Gastrointestinal Interoception Consortium (DGIC) to explore various GI disorders linked to interoceptive processing. This initiative aims to include multiple Clinical Research Centers and a Scientific Data Research Center, focusing on multidisciplinary approaches to uncover mechanisms connecting GI function to symptoms. The effort seeks to identify biomarkers and novel therapeutic targets for future clinical trials, enhancing understanding and treatment of complex gastrointestinal conditions.

The Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs) program invites applications to enhance communication and collaboration among researchers in digestive and liver diseases. Funded by the NIDDK, DDRCCs focus on shared resources that foster productivity and innovative research ideas. Each center must revolve around a central theme aligned with the NIDDK's mission, ensuring effective research support while avoiding overlap with other NIH Institutes' funding areas.

The NASPGHAN Foundation Abbott Advanced Fellowship in Pediatric Nutrition offers up to $75,000 for one year of advanced training in pediatric nutrition for members of NASPGHAN. This fellowship aims to enhance pediatric nutrition expertise by supporting a well-defined clinical experience and focused research project. Eligible applicants must be MDs or DOs and members in good standing, with a preference for those seeking training at different institutions. This initiative addresses the increasing importance of pediatric nutrition in child health.

The Kenneth Rainin Foundation seeks to promote innovative research in Inflammatory Bowel Disease (IBD) by encouraging diverse perspectives from early career investigators and those underrepresented in science. The Innovator Awards do not require preliminary data and are evaluated based on the potential for innovation and scientific merit. Eligible researchers must hold advanced degrees and can apply for funding through their home institutions, fostering groundbreaking ideas that can transform IBD treatment and prevention.

The NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) supports innovative, hypothesis-driven clinical studies with a focus on diseases relevant to NIDDK. This initiative facilitates early peer review and assessment of study designs while providing essential support for operational documents. Applicants are encouraged to consult with NIDDK staff before submission to enhance the chances of success.